Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-008958

Chief Executive Officer sold 8,009 shares at $229.20 ($1,835,692)

  • Chief Executive Officer acquired 8,009 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-07 Exercise or conversion : show line 1 in the form 10b5-1 +8,009 $101.64 $814,035 463,481 D
2025-03-07 Sale : show line 2 in the form 10b5-1 −8,009 $229.20 $1,835,692 455,472 D
Open-market sales · 8,009 sh · avg $229.20 · $1,835,692

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-07 Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options −8,009 64,074 D
Loading xslF345X05/form4.xml…